亦诺微医药申请版本

(the “Company”)(Incorporated in the Cayman Islands with limited liability) WARNING Thepublication of this Application Proof is required by The Stock Exchange of Hong Kong Limited(the“StockExchange”)and the Securities and Futures Commission(the“Commission”)solely for the purpose of providinginformation to the public in Hong Kong. This Application Proof is in draft form. The information contained in it is incomplete and is subject to change which canbe material. By viewing this document, you acknowledge, accept and agree with the Company, its joint sponsors, overallcoordinators, advisers or members of the underwriting syndicate that: (a)this document is only for the purpose of providing information about the Company to the public in Hong Kong andnot for any other purposes. No investment decision should be based on the information contained in this document;(b)the publication of this document or supplemental, revised or replacement pages on the Stock Exchange’s websitedoes not give rise to any obligation of the Company, its joint sponsors, overall coordinators, advisers or membersof the underwriting syndicate to proceed with an offering in Hong Kong or any other jurisdiction. There is noassurance that the Company will proceed with the offering;(c)the contents of this document or supplemental, revised or replacement pages may or may not be replicated in full orin part in the actual final listing document;(d)the Application Proof is not the final listing document and may be updated or revised by the Company from time totime in accordance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong KongLimited;(e)thisdocument does not constitute a prospectus,offering circular,notice,circular,brochure or advertisementoffering to sell any securities to the public in any jurisdiction, nor is it an invitation to the public to make offers tosubscribe for or purchase any securities, nor is it calculated to invite offers by the public to subscribe for orpurchase any securities;(f)this document must not be regarded as an inducement to subscribe for or purchase any securities, and no suchinducement is intended;(g)neither the Company nor any of its affiliates, advisers or underwriters is offering, or is soliciting offers to buy, anysecurities in any jurisdiction through the publication of this document;(h)no application for the securities mentioned in this document should be made by any person nor would suchapplication be accepted;(i)the Company has not and will not register the securities referred to in this document under the United StatesSecurities Act of 1933, as amended, or any state securities laws of the United States;(j)as there may be legal restrictions on the publication of this document or dissemination of any information containedin this document, you agree to inform yourself about and observe any such restrictions applicable to you; and(k)the application to which this document relates has not been approved for listing and the Stock Exchange and theCommission may accept, return or reject the application for the subject public offering and/or listing. If an offer or an invitation is made to the public in Hong Kong in due course, prospective investors are reminded tomaketheir investment decisions solely based on the Company’s prospectus registered with the Registrar ofCompanies in Hong Kong, copies of which will be published to the public during the offer period. THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BEREAD IN CONJUNCTION WITH THE SECTION HEADED “WARNING” ON THE COVER OF THIS DOCUMENT. IMPORTANT IMPORTANT: If you have doubt about any of the contents in this document, you should obtain independent professional advice. (Incorporated in the Cayman Islands with limited liability) [REDACTED] Number of [REDACTED] under the [REDACTED]:[REDACTED] (subject to the [REDACTED])Number of [REDACTED]:[REDACTED] (subject to [REDACTED])Number of [REDACTED]:[REDACTED] (subject to [REDACTED] and the[REDACTED])Maximum [REDACTED]:HK$[REDACTED] per [REDACTED] plus brokerageof 1.0%, SFC transaction levy of 0.0027%, AFRCtransaction levy of 0.00015% and Stock Exchangetrading fee of 0.00565% (payable in full on[REDACTED] in Hong Kong dollars, subject torefund)Nominal value:US$0.0001 per Share[REDACTED]:[REDACTED]Joint Sponsors,[REDACTED] Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take noresponsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever forany loss howsoever arising from or in reliance upon the whole or any part of the contents of this document. A copy of this document, having attached thereto the documents specified in “Documents Delivered to the Registrar of Companies and Available on Display” inAppendix V to this document, has been registered by the Registr